PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 138 filers reported holding PROTAGONIST THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $475,463 | -34.0% | 28,505 | +9.2% | 0.00% | -25.0% |
Q2 2023 | $720,716 | +39.5% | 26,094 | +16.2% | 0.00% | +33.3% |
Q1 2023 | $516,488 | +115.1% | 22,456 | +2.0% | 0.00% | +50.0% |
Q4 2022 | $240,118 | +30.5% | 22,009 | +0.8% | 0.00% | +100.0% |
Q3 2022 | $184,000 | +8.2% | 21,845 | +1.4% | 0.00% | 0.0% |
Q2 2022 | $170,000 | -67.7% | 21,537 | -3.0% | 0.00% | -66.7% |
Q1 2022 | $526,000 | -35.3% | 22,210 | -6.6% | 0.00% | -25.0% |
Q4 2021 | $813,000 | +87.3% | 23,772 | -2.9% | 0.00% | +100.0% |
Q3 2021 | $434,000 | -58.3% | 24,483 | +5.7% | 0.00% | -50.0% |
Q2 2021 | $1,040,000 | +95.5% | 23,165 | +12.9% | 0.00% | +100.0% |
Q1 2021 | $532,000 | +44.2% | 20,527 | +12.2% | 0.00% | +100.0% |
Q4 2020 | $369,000 | +4.2% | 18,303 | +1.0% | 0.00% | -50.0% |
Q3 2020 | $354,000 | +45.1% | 18,115 | +31.2% | 0.00% | +100.0% |
Q2 2020 | $244,000 | +229.7% | 13,809 | +32.3% | 0.00% | – |
Q1 2020 | $74,000 | -5.1% | 10,439 | -5.5% | 0.00% | – |
Q4 2019 | $78,000 | -39.5% | 11,041 | +2.7% | 0.00% | -100.0% |
Q3 2019 | $129,000 | +10.3% | 10,755 | +11.5% | 0.00% | – |
Q2 2019 | $117,000 | +85.7% | 9,642 | +32.4% | 0.00% | – |
Q1 2018 | $63,000 | -60.6% | 7,285 | -5.1% | 0.00% | -100.0% |
Q4 2017 | $160,000 | +44.1% | 7,677 | +22.1% | 0.00% | – |
Q3 2017 | $111,000 | +68.2% | 6,288 | +8.1% | 0.00% | – |
Q2 2017 | $66,000 | +13.8% | 5,818 | +27.5% | 0.00% | – |
Q1 2017 | $58,000 | – | 4,564 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 2,449,183 | $20,647,000 | 6.08% |
Bain Capital Life Sciences Investors, LLC | 2,260,572 | $19,057,000 | 2.28% |
Kynam Capital Management, LP | 519,212 | $4,377,000 | 0.92% |
RTW INVESTMENTS, LP | 4,176,837 | $35,211,000 | 0.81% |
Tri Locum Partners LP | 199,500 | $1,682,000 | 0.46% |
Birchview Capital, LP | 38,000 | $320,000 | 0.22% |
Gratus Capital, LLC | 206,113 | $1,738,000 | 0.18% |
FARALLON CAPITAL MANAGEMENT LLC | 3,651,887 | $30,785,000 | 0.17% |
PDT Partners, LLC | 126,038 | $1,063,000 | 0.16% |
FOX RUN MANAGEMENT, L.L.C. | 40,683 | $343,000 | 0.13% |